-
THE NUMBER NEEDED TO TREAT WITH DUPILUMAB TO PREVENT MODERATE OR SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATIONS AND IMPROVE SYMPTOMS: BOREAS AND NOTUS POST HOC ANALYSIS
Mar 18, 2026, 21:38 PM -
REAL-WORLD CHARACTERISTICS AND TREATMENT PATTERNS OF PATIENTS TREATED WITH TALAZOPARIB + ENZALUTAMIDE FOR METASTATIC CASTRATION-RESISTANT PROSTATE CANCER IN THE US COMMUNITY ONCOLOGY SETTING
Mar 18, 2026, 21:38 PM -
ADDRESSING MISSING DATA AND CONFOUNDING IN ACUTE KIDNEY INJURY RISK COMPARISON BETWEEN CORONARY ARTERY BYPASS GRAFTING AND PERCUTANEOUS CORONARY INTERVENTION USING MULTIPLE IMPUTATION AND PROPENSITY SCORE MATCHING
Mar 18, 2026, 21:38 PM -
SOURCES OF HOSPITAL ADMISSION COSTS IN HTA SUBMISSIONS IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM
Mar 18, 2026, 21:38 PM -
ECONOMIC IMPACT OF EARLIER DETECTION AND THERAPEUTIC MANAGEMENT OF LEPTOMENINGEAL METASTASES USING CNSIDE: A COST-OF-CARE ANALYSIS
Mar 18, 2026, 21:38 PM -
FINANCIAL COSTS OF PROVIDING ORAL PRE- AND POST-EXPOSURE PROPHYLAXIS VIA PHARMACIES IN KENYA
Mar 18, 2026, 21:38 PM -
IMPACT OF LIPID-LOWERING THERAPIES ON TRIGLYCERIDE LEVELS IN US PATIENTS WITH ASCVD IN THE REAL-WORLD
Mar 18, 2026, 21:38 PM -
ATTRIBUTE MINING FOR DISCRETE CHOICE EXPERIMENTS ACROSS DISEASES USING GEN-AI: REPLICATION AND VALIDATION OBJECTIVES
Mar 18, 2026, 21:38 PM -
REAL-WORLD DOSING AND DISCONTINUATION OF HYPERTENSION THERAPIES: INSIGHTS FROM A NATIONAL PHARMACY DATABASE
Mar 18, 2026, 21:38 PM -
VALIDATION OF THE HEPARIN-INDUCED THROMBOCYTOPENIA DIAGNOSIS CODE USING A LARGE-SCALE ELECTRONIC HEALTH RECORD DATABASE
Mar 18, 2026, 21:38 PM -
TARGETED LITERATURE REVIEW TO IDENTIFY US CLAIMS-BASED ALGORITHMS FOR ALZHEIMER’S DISEASE
Mar 18, 2026, 21:38 PM -
INCREASING EFFICIENCY OF SYSTEMATIC LITERATURE REVIEWS: ARE MULTIPLE DATABASES NECESSARY?
Mar 18, 2026, 21:38 PM -
THE PATTERNS OF COUPON OFFSETS IN GLUCAGON-LIKE PEPTIDE AGONIST USE:EVIDENCE FROM NATIONAL, ALL-PAYER PHARMACY CLAIMS
Mar 18, 2026, 21:38 PM -
COMPARATIVE RISK OF PSYCHIATRIC OUTCOMES WITH GLP-1RAS ACROSS METABOLIC INDICATIONS: A POPULATION-BASED RETROSPECTIVE COHORT STUDY
Mar 18, 2026, 21:38 PM -
MULTI-INDICATION BUDGET IMPACT ANALYSIS OF SUBCUTANEOUS IGPRO20 PRE-FILLED SYRINGES FOR THE TREATMENT OF PID, SID, AND CIDP IN ITALY
Mar 18, 2026, 21:38 PM -
A SEQUENTIAL MATCHING APPROACH TO ADDRESS IMMORTAL TIME BIAS: APPLICATION TO THE MGUS STUDY
Mar 18, 2026, 21:38 PM -
INTEGRATION OF PATIENT-REPORTED OUTCOME MEASURES IN LOWER URINARY TRACT SYMPTOMS ATTRIBUTED TO BENIGN PROSTATIC HYPERPLASIA (LUTS/BPH) CARE: QUALITATIVE INSIGHTS FOR IMPLEMENTATION STRATEGIES
Mar 18, 2026, 21:38 PM -
EARLY PATTERNS IN SECOND ORPHAN DRUG DESIGNATIONS FOLLOWING EXPANSION OF THE ORPHAN DRUG EXCLUSION
Mar 18, 2026, 21:38 PM -
PREDICTORS OF PATIENT-DIRECTED DISCHARGE AMONG EMERGENCY DEPARTMENT PATIENTS WITH OPIOID USE DISORDER
Mar 18, 2026, 21:38 PM -
A COST CALCULATOR FOR ESTIMATING DIRECT MEDICAL COST AVOIDANCE FROM SECOND-LINE SELADELPAR USE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS
Mar 18, 2026, 21:38 PM
